Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 醫學院 > 醫學系 > 期刊論文 > Item 310903500/3753

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/3753

题名:	Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
作者:	洪耀欽(Yao-Ching Hung);洪耀欽(Yao-Ching Hung);(Shiau YC);張維君(Chang,Wei-Chun);高嘉鴻(Kao,Chia-Hung);林正介(Lin,Cheng-Chieh)
贡献者:	醫學院醫學系學士班婦產學科;中國附醫婦產部
日期:	2002-07
上传时间:	2009-08-20 18:50:14 (UTC+8)
摘要:	The establishment of new tumor marker combinations including strong lead-time effects in detecting recurrent cervical cancer appears to be warranted. This retrospective study includes 50 patients with recurrent squamous cell cervical cancer after operation or radiotherapy. The serial serum levels of the tumor markers tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC) were determined. Cutoff values of 78.5 U/L for TPS and 1.5 microg/L for SCC were selected according to the 95th percentile of serum concentrations measured in healthy control patients. Comparing with other monitoring modalities, SCC and TPS showed lead-time effective in 27 and 30 cases, respectively. This difference was not statistically significant. The combination of SCC and TPS provided lead-time effects in 42 cases. Our data indicate that combination of TPS and SCC is a valuable tool in the early predicting recurrent cervical cancer.
關聯:	NEOPLASMA 49(6):415~417
显示于类别:	[醫學系] 期刊論文

文件中的档案:

档案	大小	格式	浏览次数
	58Kb	Unknown	278	检视/开启

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章